 |
| Wiley |
Angus, C., Holmes, J., 2018.
The allure, and challenges, of complexity in epidemiological modelling of
alcohol harm: Commentary on Rehm. Drug Alcohol Review. doi:10.1111/dar.12890
Archer, R., Hock, E.,
Hamilton, J., Stevens, J., Essat, M., Poku, E., Clowes, M., Pandor, A.,
Stevenson, M., 2018. Assessing prognosis and prediction of treatment response
in early rheumatoid arthritis: systematic reviews. Health Technology Assessment.
(Rockv). 22, 1–294. doi:10.3310/hta22660
Bell Gorrod, H., Latimer, N.R.,
Damian, D., Hettle, R., Harty, G.T., Wong, S.L., n.d. Impact of Non-Randomised
Dropout on Treatment Switching Adjustment in the Relapsing-Remitting Multiple
Sclerosis CLARITY Trial and the CLARITY Extension Study. Value in Health.
Bond, V., Ngwenya, F., Murray,
E., Ngwenya, N., Viljoen, L., Gumede, D., Bwalya, C., Mantantana, J.,
Hoddinott, G., Dodd, P.J., Ayles, H., Simwinga, M., Wallman, S., Seeley, J.,
2018. Value and Limitations of Broad Brush Surveys Used in Community-Randomized
Trials in Southern Africa. Qualitative Health Research 1049732318809940.
doi:10.1177/1049732318809940
Booth, A., 2019. Harnessing
Energies, Resolving Tensions: Acknowledging a Dual Heritage for Qualitative
Evidence Synthesis. Qualitative Health Research. 29, 18–31. doi:10.1177/1049732318808247
 |
| ISPOR - Value in Health |
Brazier, J.E., Rowen, D.L.,
Lloyd, A., Karimi, M., n.d. Future directions in valuing benefits for
estimating QALYs: is time up for the EQ-5D? Value in Health.
Bullement, A., Latimer,
N.R., Bell Gorrod, H., 2018. Survival Extrapolation in Cancer Immunotherapy: A
Validation-Based Case Study. Value in Health. doi:10.1016/j.jval.2018.10.007
Campbell, F., Weeks, L.,
Booth, A., Smith, A., Kneulis, D., n.d. Rapid Qualitative Reviews - What, Why,
How and Where next?, in: 25th Cochrane Colloquium Conference Abstracts.
Chambers, D., Booth, A.,
Rodgers, M., Preston, L., Dalton, J., Goyder, E., Thomas, S., Parker, G.,
Street, A., Eastwood, A., n.d. Evidence to support delivery of effective health
services: a responsive programme of rapid evidence synthesis. Evidence and Policy.
Chambers, D., Cantrell, A.,
Johnson, M., Preston, L., Baxter, S., Booth, A., Turner, J., n.d. Digital and
online symptom checkers and health assessment/triage services for urgent care:
a systematic review. Health Service Delivery Research.
 |
| Quality of Life Research |
Chuang, L.-H., Cohen, A.T.,
Agnelli, G., Gumbs, P.D., Bauersachs, R., Kroep, S., Gitt, A.K., Monreal, M.,
Willich, S.N., van Hout, B., 2019. Comparison of quality of life measurements:
EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and
deep vein thrombosis. Quality of Life Research. doi:10.1007/s11136-018-2081-3
Franklin, M., Thorn, J.,
2019. Self-reported and routinely collected electronic healthcare resource-use
data for trial-based economic evaluations: the current state of play in England
and considerations for the future. BMC Medical Research Methodology 19, 8.
doi:10.1186/s12874-018-0649-9
Gibbs, N., Powell, P.A.,
Tsuchiya, A., 2019. Equal access for equal need: Eliciting public preferences
for access to health treatment by employment status. Social Science Medicine.
doi:10.1016/j.socscimed.2019.01.003
Horner, D., Pandor, A.,
Goodacre, S., Clowes, M., Hunt, B.J., 2018. Individual risk factors predictive
of venous thromboembolism in patients with temporary lower limb immobilisation
due to injury: a systematic review. Journal of Thrombosis and Haemostasis. doi:10.1111/jth.14367
Keetharuth, D., Bjorner,
J.B., Barkham, M., Browne, J., Croudace, T., Brazier, J., 2018. Exploring the
item sets of the Recovering Quality of Life (ReQoL) measures using factor
analysis. Quality of Life Research. doi:10.1007/s11136-018-2091-1
 |
| BMC Public Health |
Kristensen, F.B., Husereau,
D., Huić, M., Drummond, M., Berger, M.L., Bond, K., Augustovski, F., Booth, A.,
Bridges, J.F.P., Grimshaw, J., IJzerman, M.J., Jonsson, E., Ollendorf, D.A.,
Rüther, A., Siebert, U., Sharma, J., Wailoo, A., 2018. Identifying the Need for
Good Practices in Health Technology Assessment: Summary of the ISPOR HTA
Council Working Group Report on Good Practices in HTA. Value in Health.
doi:10.1016/j.jval.2018.08.010
Norström, T., Angus, C.,
Ramstedt, M., Andréasson, S., Chikritzhs, T., Gripenberg, J., Holder, H.,
Holmes, J., Mäkelä, P., 2018. Estimating the public health impact of disbanding
a government alcohol monopoly: Application of new methods to the case of
Sweden. BMC Public Health 18. doi:10.1186/s12889-018-6312-x
Nyakang’o, S.B., Booth, A.,
2018. Women’s perceived barriers to giving birth in health facilities in rural
Kenya: A qualitative evidence synthesis. Midwifery 67, 1–11.
doi:10.1016/j.midw.2018.08.009
Ren, S., Squires, H., Hock,
E., Kaltenthaler, E., Rawdin, A., Alifrangis, C., 2018. Pembrolizumab for
Locally Advanced or Metastatic Urothelial Cancer Where Cisplatin is Unsuitable:
An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics. doi:10.1007/s40273-018-0750-2
Stolk, E., Ludwig, K., Rand,
K., van Hout, B., Ramos-Goñi, J.M., 2019. Overview, Update, and Lessons Learned
From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L
Valuation Protocol. Value in Health. doi:10.1016/j.jval.2018.05.010
Uttley, L., Carlton, J.,
Woods, H.B., Brazier, J., 2018. A review of quality of life themes in Duchenne
muscular dystrophy for patients and carers. Health Quality Life Outcomes 16.
doi:10.1186/s12955-018-1062-0
Webster, L., Angus, C.,
Brennan, A., Gillespie, D., n.d. Smoking and the risks of adult diseases. Report
– Figshare. doi:10.15131/shef.data.7411451